219 related articles for article (PubMed ID: 35616281)
1. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
Zewail M; E Gaafar PM; Ali MM; Abbas H
Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
3. Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines.
Zaki RM; Alkharashi LA; Sarhan OM; Almurshedi AS; Aldosari BN; Said M
Int J Pharm X; 2023 Dec; 6():100208. PubMed ID: 37680878
[TBL] [Abstract][Full Text] [Related]
4. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
5. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.
Salah S; Mahmoud AA; Kamel AO
Drug Deliv; 2017 Nov; 24(1):846-856. PubMed ID: 28535740
[TBL] [Abstract][Full Text] [Related]
6. Cubic nanoparticles as potential carriers for a natural anticancer drug: development, in vitro and in vivo characterization.
Abdou R; Mojally M; Attia HG; Dawoud M
Drug Deliv Transl Res; 2023 Oct; 13(10):2463-2474. PubMed ID: 37010791
[TBL] [Abstract][Full Text] [Related]
7. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
[TBL] [Abstract][Full Text] [Related]
8. Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies.
Faisal MM; Gomaa E; Ibrahim AE; El Deeb S; Al-Harrasi A; Ibrahim TM
AAPS PharmSciTech; 2024 May; 25(5):95. PubMed ID: 38710921
[TBL] [Abstract][Full Text] [Related]
9. Fabrication and Assessment of Orodispersible Tablets Loaded with Cubosomes for the Improved Anticancer Activity of Simvastatin against the MDA-MB-231 Breast Cancer Cell Line.
Zaki RM; El Sayeh Abou El Ela A; Almurshedi AS; Aldosari BN; Aldossari AA; Ibrahim MA
Polymers (Basel); 2023 Apr; 15(7):. PubMed ID: 37050387
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes.
Ali MA; Kataoka N; Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
Chem Pharm Bull (Tokyo); 2017; 65(1):42-48. PubMed ID: 28049915
[TBL] [Abstract][Full Text] [Related]
11. QbD-based optimization of raloxifene-loaded cubosomal formulation for transdemal delivery: ex vivo permeability and in vivo pharmacokinetic studies.
Gupta T; Kenjale P; Pokharkar V
Drug Deliv Transl Res; 2022 Dec; 12(12):2979-2992. PubMed ID: 35462597
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib-Loaded Cubosomal Nanoparticles as a Therapeutic Approach for
Alshawwa SZ; El-Masry TA; Nasr M; Kira AY; Alotaibi HF; Sallam AS; Elekhnawy E
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764091
[TBL] [Abstract][Full Text] [Related]
13. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Resveratrol Loaded Cubosomal Nanoformulation for Topical Delivery.
Kurangi B; Jalalpure S; Jagwani S
Curr Drug Deliv; 2021; 18(5):607-619. PubMed ID: 32881670
[TBL] [Abstract][Full Text] [Related]
15. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.
Nasr M; Ghorab MK; Abdelazem A
Acta Pharm Sin B; 2015 Jan; 5(1):79-88. PubMed ID: 26579429
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of cubosomes containing colchicine for transdermal delivery.
Nasr M; Younes H; Abdel-Rashid RS
Drug Deliv Transl Res; 2020 Oct; 10(5):1302-1313. PubMed ID: 32399604
[TBL] [Abstract][Full Text] [Related]
18. Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation.
Badie H; Abbas H
Drug Dev Ind Pharm; 2018 Dec; 44(12):2013-2025. PubMed ID: 30095009
[TBL] [Abstract][Full Text] [Related]
19. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of salbutamol from cubosomal gel for management of paediatric asthma:
Zhang H; Cui Y; Zhang X; Yuan X; Xu D; Zhang L
J Microencapsul; 2022 May; 39(3):252-260. PubMed ID: 35384781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
